SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.64%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$703M
AUM Growth
+$703M
(+24%)
Cap. Flow
+$36.3M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
37.2%
Holding
186
New
62
Increased
29
Reduced
37
Closed
42
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$25.3M |
| 2 |
AbbVie
ABBV
|
$23.8M |
| 3 |
Merck
MRK
|
$21.6M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 5 |
Amgen
AMGN
|
$17.8M |
Top Sells
| 1 |
Ormat Technologies
ORA
|
$34.5M |
| 2 |
Novartis
NVS
|
$33.5M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$18.2M |
| 4 |
Biogen
BIIB
|
$12.7M |
| 5 |
ISRL
Isramco Inc
ISRL
|
$11.1M |
Sector Composition
| 1 | Healthcare | 73.44% |
| 2 | Technology | 3.56% |
| 3 | Industrials | 2.47% |
| 4 | Consumer Discretionary | 2.06% |
| 5 | Utilities | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
PTC Therapeutics
PTCT
$4.41B
| $4.26M | 0.44% |
70,000
-40,000
| -36% | -$2.43M |
|
|
ICPT
52
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.23M | 0.44% |
15,000
+5,000
| +50% | +$1.41M |
|
|
53
Biogen
BIIB
$20.8B
| $4.22M | 0.44% |
10,000
-30,000
| -75% | -$12.7M |
|
54
Starbucks
SBUX
$99.2B
| $4.13M | 0.43% |
87,308
+63,308
| +264% | +$3M |
|
55
A.O. Smith
AOS
$9.92B
| $4.05M | 0.42% |
+61,600
| New | +$4.05M |
|
|
KITE
56
DELISTED
Kite Pharma, Inc.
KITE
| $3.81M | 0.4% |
65,970
-45,000
| -41% | -$2.6M |
|
|
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.8M | 0.4% |
100,023
+30,023
| +43% | +$1.14M |
|
|
ARIA
58
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.67M | 0.38% |
+445,000
| New | +$3.67M |
|
59
SPDR Euro Stoxx 50 ETF
FEZ
$4.5B
| $3.65M | 0.38% |
+94,000
| New | +$3.65M |
|
|
ITCI
60
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.58M | 0.37% |
+150,000
| New | +$3.58M |
|
61
Prothena Corp
PRTA
$452M
| $3.36M | 0.35% |
88,133
+25,501
| +41% | +$972K |
|
62
Esperion Therapeutics
ESPR
$490M
| $3.33M | 0.35% |
+36,000
| New | +$3.33M |
|
63
TJX Companies
TJX
$155B
| $3.32M | 0.35% |
47,330
-20,300
| -30% | -$1.42M |
|
|
SAGE
64
DELISTED
Sage Therapeutics
SAGE
| $3.3M | 0.34% |
65,724
-14,000
| -18% | -$703K |
|
65
Puma Biotechnology
PBYI
$258M
| $3.26M | 0.34% |
13,796
-6,500
| -32% | -$1.53M |
|
66
iShares MSCI Germany ETF
EWG
$2.49B
| $3.22M | 0.34% |
+108,000
| New | +$3.22M |
|
|
GWPH
67
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.19M | 0.33% |
+35,000
| New | +$3.19M |
|
|
VIRX
68
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.19M | 0.33% |
+1,300,000
| New | +$3.19M |
|
69
VF Corp
VFC
$5.79B
| $3.18M | 0.33% |
+42,170
| New | +$3.18M |
|
|
ORBK
70
DELISTED
Orbotech Ltd
ORBK
| $3.15M | 0.33% |
196,622
-84,250
| -30% | -$1.35M |
|
|
AEGR
71
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $3.14M | 0.33% |
120,000
-40,000
| -25% | -$1.05M |
|
72
Perrigo
PRGO
$3.21B
| $3.05M | 0.32% |
+18,400
| New | +$3.05M |
|
73
Neurocrine Biosciences
NBIX
$13.5B
| $2.98M | 0.31% |
75,000
+25,000
| +50% | +$993K |
|
|
MRTX
74
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.93M | 0.31% |
+100,000
| New | +$2.93M |
|
|
KERX
75
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.93M | 0.3% |
230,000
+30,000
| +15% | +$382K |
|